详情
Manufacturer
Merck Sharp & Dohme
Registraction Number
MAL20071664ACRZ
Content
- Each tablet contains 100 mg of sitagliptin phosphate monohydrate, the active ingredient.
Indication
- Januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- It can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin when these alone do not provide adequate control.
Instructions for Use
- Recommended dose: 100 mg once daily.
- Januvia can be taken with or without food.
- Dosage adjustments are necessary for patients with renal impairment:
- For moderate renal impairment (eGFR ≥30 to <45 mL/min/1.73 m²): 50 mg once daily.
- For severe renal impairment (eGFR ≥15 to <30 mL/min/1.73 m²) or end-stage renal disease (eGFR <15 mL/min/1.73 m²) requiring hemodialysis or peritoneal dialysis: 25 mg once daily.
更多 Complete Wellness 相关资料
Malaysia
